← Leaderboards

Nancy S. Green

Columbia University Health Sciences

Google Scholar ↗PubMed ↗ORCID ↗

$2,916,455

Attributed

$5,832,910

Total exposure

4

Grants

2

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY2013–25

$2M$1.5M$1M$500K$0

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$7,869,141 · 5

By mechanism

R01$5,103,239 · 2

U2C$2,036,231 · 1

R21$729,671 · 2

Top collaborators

Most similar at Columbia University Health Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Sickle Cell Anemia”

Russell E Ware · Duke University$48,435,687
Michael Rutledge Debaun · Vanderbilt University Medical Center$38,268,866
Martin H. Steinberg · Boston Medical Center$25,628,557
Michael L. Terrin · Clinical Trials And Surveys Corporation$23,855,067
Barbara L Kroner · Research Triangle Institute$21,141,016
Garret A Fitzgerald · University Of Pennsylvania$20,602,198

Research focus

Sickle Cell AnemiaChildChildhoodAnemiaSamplingHospitalsFundingAffectBiological MarkersHydroxyureaClinical TrialsCommunitiesPharmaceutical PreparationsClinicEnsureBaseInfarctionMorbidity - Disease RateCross-Sectional StudiesCerebrovascular CirculationMagnetic Resonance ImagingHematological DiseaseImpaired CognitionBrain Injuries

Grant awards (19)

New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)$522,111

U2C · FY2025 · DK

New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)$469,899

U2C · FY2024 · DK

New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)$522,110

U2C · FY2023 · DK

Burden and Risk of Neurological and Cognitive Impairment in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE II)$389,531

R01 · FY2023 · HD

Burden and Risk of Neurological and Cognitive Impairment in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE II)$132,434

R01 · FY2023 · HD

New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)$522,111

U2C · FY2022 · DK

Burden and Risk of Neurological and Cognitive Impairment in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE II)$390,950

R01 · FY2022 · HD

Burden and Risk of Neurological and Cognitive Impairment in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE II)$386,000

R01 · FY2021 · HD

Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT$704,117

R01 · FY2020 · NR · contact PI

Burden and Risk of Neurological and Cognitive Impairment in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE II)$401,623

R01 · FY2020 · HD

Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT$735,962

R01 · FY2019 · NR · contact PI

Burden and Risk of Neurological and Cognitive Impairment in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE II)$464,236

R01 · FY2019 · HD

Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT$739,957

R01 · FY2018 · NR · contact PI

Burden and Risk of Neurological and Cognitive Impairment in Pediatric Sickle Cell Anemia in Uganda$49,992

R21 · FY2018 · HD

Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT$758,429

R01 · FY2017 · NR · contact PI

Burden and Risk of Neurological and Cognitive Impairment in Pediatric Sickle Cell Anemia in Uganda$135,000

R21 · FY2017 · HD

Burden and Risk of Neurological and Cognitive Impairment in Pediatric Sickle Cell Anemia in Uganda$132,880

R21 · FY2016 · HD

Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT$177,503

R21 · FY2014 · NR · contact PI

Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT$234,296

R21 · FY2013 · NR · contact PI